Please enter a valid ZIP code
Control Bleeds
Clock 5 Hours

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]). Fast from the start. Fast to the finish.

  • When it comes to mixing speed and
    administration Tooltip Administration
    In hemophilia, to apply to the body through infusion.
    Tooltip
    , NovoSeven® RT is like no
    other bypassing agent Tooltip Bypassing agent
    A product that treats a bleed without the need for Factor VIII (8) or Factor IX (9).
    Tooltip
  • After entering the bloodstream, NovoSeven® RT
    starts working at the site of the
    injury to help form a stable clot Tooltip Clot
    The thickened mass of blood and cells your body forms to stop the bleeding at the place where you have been injured.
    Tooltip
  • NovoSeven® RT stops joint bleeds Tooltip Bleed
    In hemophilia, a collection of blood in an area, such as a muscle or joint.
    Tooltip

    in as few as 5 hours with as
    few as 2 doses*

For bleeds that require more than 1 dose...why wait?

  • With NovoSeven® RT: You can readminister as quickly as every 2 hours
  • With plasma Tooltip Plasma
    The fluid part of the blood that contains clotting factors and other proteins.
    Tooltip
    -derived bypassing agents (FEIBA®): You have to wait 12 hours before you can readminister

*Median of 2 doses.
In a study of patients with hemophilia A or B with and without inhibitors.
Based on individual dosage for joint bleeds in patients with hemophilia A or B with inhibitors.

Copy Corner
Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

Side Effects

Use with Other Drugs

Please click here for NovoSeven® RT Prescribing Information and Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch,
or call 1-800-FDA-1088.

NovoSeven® RT is a prescription medicine. Novo Nordisk provides patient assistance for those who qualify. Please call 1-877-NOVO-777 (1-877-668-6777) to learn more about Novo Nordisk assistance programs.